"When I am lying in bed waiting for an acute flare-up of nausea to subside, I feel so depressed that I can’t help wondering ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

Whey, the liquid byproduct of making cheese, was once considered waste. It's now a key ingredient in the protein powders that ...

Miriam Margolyes said that she’s let her body down as she continues to deal with multiple health conditions. The Harry Potter ...

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions ...

More than 40 years ago, Apollonia Kotero met Prince when she auditioned to play his love interest in 1984’s Purple Rain. She ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Dr Shazia Malik - a consultant obstetrician and gynaecologist for The Portland Hospital - discussed the pros and cons of ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

Fans rubbed their eyes in disbelief after Meghan Trainor shared a video of herself attempting a wild and risky challenge ...

Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a simple matter of exercise.